Ulimorelin
- Generic Name
- Ulimorelin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C30H39FN4O4
- CAS Number
- 842131-33-3
- Unique Ingredient Identifier
- LGI67MCW2S
- Background
Ulimorelin is a novel small molecule ghrelin agonist being developed by Tranzyme Pharma as a first-in-class treatment for both POI and diabetic gastroparesis, serious medical conditions in which motility of the GI tract is severely impaired.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath